![](/img/cover-not-exists.png)
Phase I Interim Safety and Efficacy of Venetoclax (ABT-199/GDC-0199) Monotherapy for Relapsed/Refractory (R/R) Multiple Myeloma (MM)
Kumar, S., Vij, R., Kaufman, J.L., Mikhael, J., Facon, T., Moreau, P., Amiot, M., Alzate, S., Morris, L., Ross, J., Dunbar, M., Zhu, M., Agarwal, S., Leverson, J., Enschede, S., Humerickhouse, R., TouVolume:
15
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2015.07.630
Date:
September, 2015
File:
PDF, 70 KB
english, 2015